Sarepta Sells Biotech Stake to Raise Cash as Elevidys Troubles Hit Home

Published 2 months ago Negative
Sarepta Sells Biotech Stake to Raise Cash as Elevidys Troubles Hit Home
Auto

Related Stocks

AB3A.BE SAREPTA THERAP AB3A.MU SAREPTA THERAP HDP1.BE ARROWHEAD RESEA... HDP1.MU ARROWHEAD RESEA... S1RP34.SA Sarepta Therape...
The stock has been in free fall since safety issues derailed a gene therapy analysts had expected to achieve blockbuster sales.

Continue Reading

View Comments

More News

Saudi Arabia Plastic Recycling Market Analysis Report 2025-2034: Increasing Demand for Polyethylene Terephthalate (PET) to Aid Growth

17 hours ago Positive

Saudi Arabia Pet Care Analysis, Forecast Trends and Outlook Report 2025-2034: Market to Grow at a CAGR of 7.2%, Fueled by Growing Birds Segment and Increasing Affordability of Pet Care Products

17 hours ago Positive

Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

17 hours ago Neutral

EUR/USD holds in range as US government reopening hopes lift mood

21 hours ago Negative

NZD/USD hovers around 0.5640, downside likely on RBNZ rate cut bets

21 hours ago Negative